2,066
Views
29
CrossRef citations to date
0
Altmetric
Review

Efficacy of biologics in atopic dermatitis

&
Pages 525-538 | Received 01 Nov 2019, Accepted 25 Jan 2020, Published online: 03 Feb 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Carla Tubau & Lluís Puig. (2021) Therapeutic targeting of the IL-13 pathway in skin inflammation. Expert Review of Clinical Immunology 17:1, pages 15-25.
Read now

Articles from other publishers (28)

Stuti Prajapati, Mohammad Fardos, Amar D Desai & Steven R Feldman. (2023) The role of lebrikizumab in the treatment of atopic dermatitis in the adult population. Immunotherapy 15:13, pages 981-991.
Crossref
Alan D. Irvine, Thishi Surendranathan, Liz Hennessy, Ivana Rajkovic, Annette Durkan, Dearbhla Coughlan, Sean Conlon & Richard Hudson. (2023) A real‐world retrospective observational study exploring resource use for secondary care management of moderate‐to‐severe atopic dermatitis in children and adolescents at a single site in Ireland. JEADV Clinical Practice.
Crossref
Jeanmarie R. Gonzalez, Anna Celli, Antonin Weckel, Miqdad O. Dhariwala, Geil R. Merana, Oluwasunmisola T. Ojewumi, Joy Okoro, Laura R. Dwyer, Victoria M. Tran, Jason M. Meyer, Theodora M. Mauro & Tiffany C. Scharschmidt. (2023) FLG Deficiency in Mice Alters the Early-Life CD4+ T-Cell Response to Skin Commensal Bacteria. Journal of Investigative Dermatology 143:5, pages 790-800.e12.
Crossref
Ana B. Pavel, Ester Del Duca, Julia Cheng, Jianni Wu, Benjamin Ungar, Yeriel D. Estrada, Carolyn Jack, Catherine Maari, Étienne Saint‐Cyr Proulx, Francisco Ramirez‐Valle, James G. Krueger, Robert Bissonnette & Emma Guttman‐Yassky. (2022) Delayed type hypersensitivity reactions to various allergens may differently model inflammatory skin diseases. Allergy 78:1, pages 178-191.
Crossref
Yujin Kwon, Su-Yeon Cho, Jaeyoung Kwon, Min Hwang, Hoseong Hwang, Yoon Jin Kang, Hyeon-Seong Lee, Jiyoon Kim & Won Kyu Kim. (2022) Anti-atopic dermatitis effects of Parasenecio auriculatus via simultaneous inhibition of multiple inflammatory pathways . BMB Reports 55:6, pages 275-280.
Crossref
Linda Tizek, Maximilian C. Schielein, Lucas Tizek & Alexander Zink. (2022) Atopische Dermatitis – Identifikation von Bedürfnissen der deutschen Bevölkerung mittels InternetsuchanfragenAtopic dermatitis—identifying needs in the German population by internet search queries. Der Hautarzt 73:6, pages 475-484.
Crossref
Helen A. Brough, Bruce Joshua Lanser, Sayantani B. Sindher, Joyce M. C. Teng, Donald Y. M. Leung, Carina Venter, Susan M. Chan, Alexandra F. Santos, Henry T. Bahnson, Emma Guttman‐Yassky, Ruchi S. Gupta, Gideon Lack, Christina E. Ciaccio, Vanitha Sampath, Kari C. Nadeau & Cathryn R. Nagler. (2021) Early intervention and prevention of allergic diseases. Allergy 77:2, pages 416-441.
Crossref
Christopher M. Logas, Brad P. Glick & James Q. Del Rosso. (2022) The new and old: Atopic dermatitis biologics. Dermatological Reviews 3:1, pages 14-19.
Crossref
Aditya R. Darade, Maria Lapteva, Thomas Hoffmann, Markus Mandler, Achim Schneeberger & Yogeshvar N. Kalia. (2022) Effect of mRNA Delivery Modality and Formulation on Cutaneous mRNA Distribution and Downstream eGFP Expression. Pharmaceutics 14:1, pages 151.
Crossref
Thomas Bieber. (2021) Atopic dermatitis: an expanding therapeutic pipeline for a complex disease. Nature Reviews Drug Discovery 21:1, pages 21-40.
Crossref
Chen Yan, Jiang Ying, Wang lu, Yang Changzhi, Qian Qihong, Mao Jingzhu, Sun Dongjie & Zhu Tingting. (2022) MiR-1294 suppresses ROS-dependent inflammatory response in atopic dermatitis via restraining STAT3/NF-κB pathway. Cellular Immunology 371, pages 104452.
Crossref
Melvin Zhang, Jennifer L. Duffen, Karl H. Nocka & Marion T. Kasaian. (2021) IL-13 Controls IL-33 Activity through Modulation of ST2. The Journal of Immunology 207:12, pages 3070-3080.
Crossref
Takashi Nomura & Kenji Kabashima. (2021) Advances in atopic dermatitis in 2019-2020: Endotypes from skin barrier, ethnicity, properties of antigen, cytokine profiles, microbiome, and engagement of immune cells. Journal of Allergy and Clinical Immunology 148:6, pages 1451-1462.
Crossref
Filomena Russo, Nicola Milanesi, Alessandra Cartocci, Francesco Bruzziches, Greta Tronconi, Laura Lazzeri, Angelo Massimiliano D'erme, Giovanni Bagnoni, Massimo Gola, Elisa Cinotti, Pietro Rubegni & Maria Laura Flori. (2021) Dupilumab in Elderly Patients With Severe Atopic Dermatitis. Dermatitis 32:1S, pages S24-S27.
Crossref
Ana Isabel Barbosa, Tiago Torres, Sofia A. Costa Lima & Salette Reis. (2021) Hydrogels: A Promising Vehicle for the Topical Management of Atopic Dermatitis. Advanced Therapeutics 4:7, pages 2100028.
Crossref
Jianghui Meng, Yanqing Li, Michael J. M. Fischer, Martin Steinhoff, Weiwei Chen & Jiafu Wang. (2021) Th2 Modulation of Transient Receptor Potential Channels: An Unmet Therapeutic Intervention for Atopic Dermatitis. Frontiers in Immunology 12.
Crossref
Hong-jiao Qi & Lin-Feng Li. (2021) New Biologics for the Treatment of Atopic Dermatitis: Analysis of Efficacy, Safety, and Paradoxical Atopic Dermatitis Acceleration. BioMed Research International 2021, pages 1-13.
Crossref
Suvarna Samudrala. 2021. Atopic Dermatitis - Essential Issues. Atopic Dermatitis - Essential Issues.
Jowita Sroka-Tomaszewska & Magdalena Trzeciak. (2021) Molecular Mechanisms of Atopic Dermatitis Pathogenesis. International Journal of Molecular Sciences 22:8, pages 4130.
Crossref
Guido H. Falduto, Annika Pfeiffer, Andrea Luker, Dean D. Metcalfe & Ana Olivera. (2021) Emerging mechanisms contributing to mast cell-mediated pathophysiology with therapeutic implications. Pharmacology & Therapeutics 220, pages 107718.
Crossref
Carla Tubau & Lluís Puig. (2021) IL-13 antagonists in the treatment of atopic dermatitis. Immunotherapy 13:4, pages 327-344.
Crossref
Hui Ling Foo & Hong Liang Tey. (2021) A clinico-pathological approach to management of atopic dermatitis. Annals of the Academy of Medicine, Singapore 50:2, pages 171-173.
Crossref
Ana B. Pavel, Yael Renert‐Yuval, Jianni Wu, Ester Del Duca, Aisleen Diaz, Rachel Lefferdink, Milie M. Fang, Talia Canter, Stephanie M. Rangel, Ning Zhang, James G. Krueger, Amy S. Paller & Emma Guttman‐Yassky. (2020) Tape strips from early‐onset pediatric atopic dermatitis highlight disease abnormalities in nonlesional skin. Allergy 76:1, pages 314-325.
Crossref
Manuel Pereira, Stefan Salzmann, Sonja Ständer, Petra Staubach & Martin Metz. (2021) Besseres Krankheitsverständnis ermöglicht neue Therapien. Der Deutsche Dermatologe 69:1, pages 44-53.
Crossref
Jianni Wu, Ester Del Duca, Michael Espino, Alyssa Gontzes, Inna Cueto, Ning Zhang, Yeriel D. Estrada, Ana B. Pavel, James G. Krueger & Emma Guttman-Yassky. (2020) RNA Sequencing Keloid Transcriptome Associates Keloids With Th2, Th1, Th17/Th22, and JAK3-Skewing. Frontiers in Immunology 11.
Crossref
Manuel P. Pereira, Stefan Salzmann, Sonja Ständer, Petra Staubach & Martin Metz. (2020) Arzneitherapie des chronischen Pruritus – Licht am Ende des langen Tunnels?Therapy for chronic pruritus—light at the end of a long tunnel?. Der Internist 61:10, pages 1076-1086.
Crossref
Perrine Cochez, Mathilde Choteau, Nisha Limaye, Marie Baeck & Laure Dumoutier. (2020) Implication of T Helper Cytokines in Contact Dermatitis and Atopic Dermatitis. Current Treatment Options in Allergy 7:3, pages 258-273.
Crossref
M. Metz & M. P. Pereira. (2020) Moderne systemische Therapie des PruritusModern systemic therapy for pruritus. Der Hautarzt 71:7, pages 518-524.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.